RYTHM 3Q 2026: Revenue $23.9M, Net loss $533K, EPS ($0.07) — 10-Q Summary
RYTHM, Inc. reported Q3 2026 revenue of $23.9M, up 490% YoY, driven by licensing. Net loss narrowed to $533K from $10.7M YoY, with EPS at ($0.07). Nine-month revenue rose 808% to $60.2M. The company warned of potential sales declines due to upcoming federal restrictions.
How this was made

The 30-second read
Why it matters
The earnings beat and loss narrowing provide fresh material for traders, though sector risk remains high.
Market read
New earnings data could drive short‑term price movement; sector risk from pending regulations.
What to watch
Potential supply‑chain constraints and state‑level regulatory variance may affect future revenue.
Background
RYTHM, Inc. is a micro‑cap cannabis company reporting its Q3 2026 results via a 10‑Q filing.
Ticker impact
RYTHM, Inc. disclosed Q3 2026 revenue of $23.9M and a narrowed net loss of $533K in its 10‑Q filing.
potential upside as the market prices in the improved earnings profile
The sharp revenue growth and loss reduction are fresh, material data for a micro‑cap, suggesting price appreciation.
Market effects
Highlights rapid growth in the hemp‑THC licensing segment, may boost peer valuations.
U.S. hemp‑THC market faces upcoming federal restrictions, adding regulatory risk.
Limited to niche cannabis sector; minimal broader market effect.
Counterpoint
Upcoming federal restrictions could sharply curtail sales, offsetting growth momentum.
Key entities
- companyRYTHM, Inc.
Cannabis firm reporting Q3 2026 results.

